Miras, Dionne Chixx .

HRN: 16-36-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/27/2022
11/27/2022
IV
450 Mg
Q6
T/C UTI
Waiting Final Action 
11/29/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/29/2022
12/05/2022
IVT
1,800mg
Q8
Sepsis
Waiting Final Action 
12/03/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
12/03/2022
12/09/2022
ORAL
4.5ml
Od
Sepsis
Waiting Final Action 
12/07/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/07/2022
12/14/2022
IV
240mg
Q8hours
Sepsis (Staphylococcus Epidermidis)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: